Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference66 articles.
1. Burger Medicinal Chemistry and Drug Discovery;Wolff,1994
2. Mechanism-based target identification and drug discovery in cancer research;Gibbs;Science,2000
3. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents;Bandgar;Bioorg. Med. Chem.,2010
4. Genome-wide association studies: how predictable is a person’s cancer risk?;Roukos;Expert Rev. Anticancer Ther.,2009
5. Cancer is a preventable disease that requires major lifestyle changes;Anand;Pharm. Res.,2008
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53;Molecules;2024-02-04
2. Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy;Journal of Biomedical Science;2024-01-29
3. ACSS3 promotes the tumorigenesis of non-small cell lung cancer via suppressing p53-mediated ferroptosis;2024-01-02
4. MDMX in Cancer: A Partner of p53 and a p53-Independent Effector;Biologics: Targets and Therapy;2024-01
5. From Genes to Therapy: Pituitary Adenomas in the Era of Precision Medicine;Biomedicines;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3